JUN 06, 2016 12:04 PM PDT

Hand-Held Heart Attack Detector

WRITTEN BY: Xuan Pham
Emergency room doctors can now diagnose a potential heart attack in 10 minutes instead of the usual hour-long wait for routine lab results. This leap in diagnostic efficiency is thanks to a new hand-held device that analyzes cardiac-specific proteins from a single drop of blood.
 
Philips Communications





Known as the Minicare I-20, the device resembles a common label maker. But in this portable device, Philips Healthcare has packed a quite punch. The device works by measuring the level of the biomarker cardiac troponin I (cTnI), which is a heart-specific protein that leaks into the bloodstream following a heart attack. Doctors rely on the presence of this biomarker to diagnose and confirm myocardial infarction in patients who present with chest pains. But waiting for these routine lab tests cost precious time in the ER.
 
"Blood samples are usually analyzed in the hospital laboratory, which can easily take more than an hour to get the result back to the ED physician. Point-of-care testing can significantly help to reduce the turnaround time," said Paul Collinson, consultant chemical pathologist at St. George's University Hospital in the United Kingdom.
 
With the portable device, doctors can have their patient’s biomarker results even before they complete taking the patient’s medical history. And in a setting where every minute counts, the Minicare I-20 could be life-saving, especially for high-risk cardiac patients.
 
"Minicare I-20 is designed to help care providers to reduce time to treatment and reduce time to discharge of patients, thereby helping to decrease crowding in the emergency department and leading to better use of hospital resources," said Marcel van Kasteel, CEO of Handheld Diagnostics at Philips.
 
The device passed expectations in multicenter clinical studies and in real acute hospital settings. In all validation tests, the device dramatically cuts down the diagnostic time, often exceeding a turn-around time of less than 10 minutes.
 
Philips has plans to extend the applications of the Minicare I-20 to other blood tests, broadening the scope of this point-of-care device. Currently, the device has not made its way to the US market yet, but it is available in the United Kingdom, Germany, and the Netherlands.
 


Additional source: MNT
About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
DEC 04, 2019
Clinical & Molecular DX
DEC 04, 2019
Genetic platform takes the guesswork out of catching infections
A physician is faced with 3 patients: an elderly person with a chronic cough, a child being wheeled out of surgery and a ...
MAR 05, 2020
Drug Discovery & Development
MAR 05, 2020
Human Stem Cells Cure Type 1 Diabetes in Mice
In the US alone, around 187,000 children and adolescents have Type 1 diabetes, alongside 1.4 million people aged 20 and ...
MAR 29, 2020
Cancer
MAR 29, 2020
MicroRNA as a New Way to Test for Lung Cancer
The most common, and most deadly, cancer across the world is lung cancer. If caught early, lung cancer has quite a low m ...
APR 14, 2020
Clinical & Molecular DX
APR 14, 2020
Urchin-shaped DNA Biosensor Detects Disease Earlier
For researchers at the Missouri University of Science and Technology developing a new class of nanodiagnostics, good thi ...
APR 22, 2020
Drug Discovery & Development
APR 22, 2020
Only 3% of COVID-19 Antibody Tests Approved by FDA
So far, only 3% of at least 90 COVID-19 antibody tests in the US have been approved by the Food and Drug Administration ...
MAY 09, 2020
Clinical & Molecular DX
MAY 09, 2020
Rapid, Efficient COVID-19 Diagnostic Method Relies on Magnetic Beads
The pandemic virus SARS-CoV-2 has spread widely, and a lack of testing has been a serious problem.
Loading Comments...